Enabling Protein Degradation Drug Discovery

*Purity of all products >95% unless otherwise stated
  • Name
    Catalogue Number
    Size
    Price
    Add to Basket
  • Name:
    Proteaselect-HEK293_Bio-Rpn11
    Catalogue Number:
    66-5012-001
    Size:
    2-4 x106 cells in 1ml
    Price:
    P.O.A.
    Add To Basket
  • Species
    Human
  • Source
    Embryonic Kidney
  • Quantity
    2-4 x106 cells in 1ml
  • Storage
    cryopreserved
  • Concentration
    2-4 x106 cells in 1ml
  • Formulation
    DMEM high glucose (HG), 10% FBS, 2 mM L-Glutamine, 1x pen/strep
  • Molecular Weight
    Adherent
  • Stability
    P11
  • Protein Sequence
    Epithelial

The ubiquitin–proteasome system (UPS) targets selected proteins for degradation by the 26S proteasome. The initial steps in this pathway generate proteins that are covalently tagged with a polyubiquitin chain that is then recognized by ubiquitin receptors of the 26S proteasome. This is a large complex composed of a 20S catalytic core particle and two 19S regulatory particles (Kok et al., 1993) that catalyse the final step in the pathway. While the 20S particle is composed of a catalytic chamber for protein degradation, collectively the proteins that comprise the 19S particle perform several proteasomal functions that include recognition of ubiquitylated substrates, cleavage of the polyubiquitin chain for ubiquitin recycling, control of access to the 20S proteolytic chamber, and substrate unfolding and subsequent translocation into the 20S core particle for degradation (Boehringer et al., 2012). Mammalian proteasomes are associated with three DUBs: USP14, UCHL5 (UCH37) and Rpn11 (POH1). UCHL5 and USP14 reside on the regulatory particle and remove ubiquitin from the substrate before substrate degradation whereas Rpn11’s activity is delayed until the proteasome is committed to degrading the substrate (Lee et al., 2010). The DUB activity of USP14 is known to be activated by proteasomes.

To fully understand the function and regulation of the proteasome complex, an important step is to elucidate its subunit composition and posttranslational modifications. Toward this goal, Wang et al. (2007) have developed an affinity purification strategy using a derivative of the HB tag for rapid isolation of the human 26S proteasome complex for subsequent proteomic analysis. The purification of the complex is achieved from a stable HEK293 cell line expressing a HB-tagged (6His/Biotin-tagged) proteasome subunit (hRpn11) and by high-affinity streptavidin binding with TEV cleavage elution. The ‘Biotin-tag’ consists of a Biotin Acceptor Peptide sequence recognised and biotinylated by the enzyme BirA.

References:

Boehringer J, Riedinger C, Paraskevopoulos K, Johnson EO, Lowe ED, Khoudian C, et al. (2012) Structural and functional characterization of Rpn12 identifies residues required for Rpn10 proteasome incorporation. Biochem J 448, 55-65.

Kok K, Hofstra R, Pilz A, van den Berg A, Terpstra P, Buys CH, et al. (1993) A gene in the chromosomal region 3p21 with greatly reduced expression in lung cancer is similar to the gene for ubiquitin-activating enzyme. Proc Natl Acad Sci USA 90, 6071-6075.

Lee BH, Lee MJ, Park S, Oh DC, Elsasser S, Chen PC, et al. (2010) Enhancement of proteasome activity by a small-molecule inhibitor of USP14. Nature 467, 179-184.

Wang X, Chen CF, Baker PR, Chen PL, Kaiser P and Huang L (2007) Mass spectrometric characterization of the affinity-purified human 26S proteasome complex. Biochemistry 46, 3553-3565.